Our Story
2015: PharmaBlue is founded in Sophia-Antipolis (south of France) to complement BlueReg Group offerered services. PharmaBlue is a “Laboratoire Exploitant” (authorized by the ANSM) enabling innovative pharmaceutical companies to market early access medicines under ATU.
2017: PharmaBlue pharmaceutical site is moved to Paris to facilitate international exchanges.
2020: PharmaBlue’s Exploitant Establishment licensed is inspected by ANSM French National Agency for the Safety of Medicines and Health Products and successfully meet all the requirements.
2021: PharmaBlue is acquired by PharmaLex. In France, there is a major regulation change for Early Access, well handled by PharmaBlue that has obtained its first Authorization under the new regulation.
2022: PharmaBlue pursue its growth with the creation of two dedicated departments : Scientific Affairs and Quality.
2023: PharmaLex group from which PharmaBlue belongs to is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives..
2024: Valerie Colin PharmD, is appointed Head of PharmaBlue.